Pharmacy Test Visualisation v1 - DOACS

- are we storing up problems?

Oral Anti-coagulants

By Period, cost and items - first run

Note that items are rising steadily too, even if much slower than costs

Oral Anti-coagulants

Rolling 12 month total [colours as above]

One major question then - Is this a good thing, or are we missing problems?

- another is - are we getting good value from the change? - at around £2.5m per month, extra

Parenteral vs Oral Anti-coagulants

=Items Change =

We have lots of patients on DOACs - who is monitoring Adherence - and impact of the change on Adverse Event, Outcomes?

[With thanks to xkcd at xkcd.com]